Similar Articles
2251 Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits
2252 Enhancement of leukocyte adhesion after percutaneous irradiation in rats with hepatocellular carcinoma
2253 Post-radiation survival time in hepatocellular carcinoma based on predictors for CT-determined, transarterial embolization and various other parameters
2254 Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation
2255 Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival
2256 Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation
2257 Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy
2258 Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
2259 Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing
2260 Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA